Categories
Pharmaceutical

How is Rising Pelvic Cancer Burden Stimulating Demand for Radiation Proctitis Treatment

Award-winning consulting firm Fact.MR’s radiation proctitis treatment market report forecasts a positive growth trajectory for 2021 and beyond, majorly attributed to increasing frequencies of radiation therapy for various types of pelvic cancers. As per the report, the market is poised to reach nearly US$ 750 million by 2031, expanding at approximately 7% CAGR over the next ten years.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=5281

The market posted significant gains in the past, valued at over US$ 300 million in 2019. According to the International Agency for Research on Cancer, 1 in 5 people develop cancer during their lifetime, with breast cancer topping the list (~25%). Simultaneously, incidence of prostate and cervical cancer is also rising, prompting patients to seek powerful radiation treatment.

Consequently, radiation proctitis incidence has also surged, with studies advocating that external beam radiation causing incidence rates to vary anywhere between 2% to 39%, while intensity modulated radiation therapy (IMRT) incidence rates vary from 1% to 9%. Hence, prominent manufacturers are introducing a plethora of oral and surgical treatment approaches, with specific emphasis on anti-inflammatory drug production and hyperbaric oxygen therapy (HBOT).

radiation proctitis treatment market

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=5281

Key Takeaways from Market Study

  • By indication, acute radiation proctitis treatment remains dominant, with chronic radiation proctitis treatment to expand swiftly
  • Anti-inflammatory drug-based oral therapy to remain the most preferred treatment for radiation proctitis
  • Incorporation of hyperbaric oxygen therapy to fuel radiation proctitis treatment prospects across the U.S.
  • The market in the U.K. experiencing high growth amid increasing cervical cancer treatment procedures
  • Broadening cancer research funding to bolster sales of radiation proctitis treatment solutions in the German market

“Ever-increasing burden of pelvic cancer is prompting patients to seek highly effective treatment approaches, leading to a spike in radiation proctitis incidences, compelling them to seek effective treatment,” remarks a Fact.MR analyst.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/5281

Competitive Landscape

Key market players are majorly emphasizing on developing new treatment approaches, including potential drug candidates in the oncology segment, as well as concentrating on capacity expansion by virtue of collaborations and acquisitions.

  • For instance, in 2019, Sun Pharmaceutical Industries Ltd. entered into a licensing agreement with AstraZeneca UK Ltd. to introduce certain novel ready-to-use (RTU) infusion oncology products in China. As per the agreement, Sun Pharma is responsible for the development, regulatory filings, and manufacturing of the products, while AstraZeneca will exclusively distribute them across China.
  • Regarding product offerings, Sechrist Industries Ltd. offers a wide range of hyperbaric oxygen chambers, including the Monoplace Hyperbaric Chamber Gurney Storage, the Model 4100 Hyperbaric Oxygen Chamber, the Model 3600H Hyperbaric Oxygen Chamber, the Model 3300H Hyperbaric Chamber, and the Model 2800 Hyperbaric Classic Pneumatic Chamber.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2019/09/11/1914197/0/en/Peak-Flow-Meters-to-Ride-on-Portability-Quotient-Gains-Remain-Driven-by-Introduction-of-Smart-and-Efficient-Variants-Fact-MR.html

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Oral Therapy Radiation Proctitis Treatment Expected to Remain the Most Preferred: Scrutinized in the New Analysis

A recent study by Fact.MR on the radiation proctitis treatment market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering Radiation Proctitis Treatment.

The study also provides the dynamics that are responsible for influencing the future status of the market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the radiation proctitis treatment market, along with their product portfolios, enhances the reliability of this comprehensive research study.

Request For Sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=5281

Report Summary
The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of radiation proctitis treatment solutions across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of radiation proctitis treatment solutions during the forecast period. Price point comparison by region with global average price is also considered in the study.

Key Market Segments

  • Indication
    • Acute Radiation Proctitis
    • Chronic Radiation Proctitis
  • Therapy
    • Oral Therapy
      • Antidiarrheal
      • Anti-inflammatory Agents
      • Others
    • Ablative Procedures
    • Hyperbaric Oxygen Therapy
    • Formalin
    • Surgery
  • Region
    • North America (US and Canada)
    • Latin America (Brazil, Mexico and Rest of LATAM)
    • Europe (Germany, UK, France, Spain, Italy and Rest of Europe)
    • Asia-Pacific (Japan, China, India, Australia & New Zealand and Rest of APAC)
    • Middle East & Africa (GCC, South Africa and Rest of MEA)

Request For TOC- https://www.factmr.com/report/radiation-proctitis-treatment-market/toc

Key Questions Answered in Report

  • Which are the most lucrative markets for radiation proctitis treatment?
  • Which factors will impact the growth of the market?
  • How will changing trends impact the strategies of market players?
  • How can market players capture the low-hanging opportunities across regions?
  • Which companies are leading the radiation proctitis treatment industry?
  • What are the winning strategies of stakeholders in the market?

Analysis on Market Size Evaluation
The market has been analyzed for each market segment in terms of volume (‘000 Units) and value (US$ Mn).

Market estimates at global and regional levels for radiation proctitis treatment are available in terms of “US$ Mn” for value and in “‘000 Units” for volume. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global radiation proctitis treatment market.

Explore Fact.MR’s Coverage on the Healthcare Domain: 

Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.

At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.

Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Demand for Chronic Radiation Proctitis Treatment Is Poised to Reach Nearly US$ 750 million by 2031

As per the Fact.MR’s report, the Demand for Radiation Proctitis Treatment is poised to reach nearly US$ 750 million by 2031, expanding at approximately 7% CAGR over the next ten years.

The sales of radiation proctitis treatment are slated significant gains in the past, valued at over US$ 300 million in 2019. According to the International Agency for Research on Cancer, 1 in 5 people develop cancer during their lifetime, with breast cancer topping the list (~25%). Simultaneously, incidence of prostate and cervical cancer is also rising, prompting patients to seek powerful radiation treatment.

Consequently, radiation proctitis incidence has also surged, with studies advocating that external beam radiation causing incidence rates to vary anywhere between 2% to 39%, while intensity modulated radiation therapy (IMRT) incidence rates vary from 1% to 9%. Hence, prominent manufacturers are introducing a plethora of oral and surgical treatment approaches, with specific emphasis on anti-inflammatory drug production and hyperbaric oxygen therapy (HBOT).

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=5281

“Ever-increasing burden of pelvic cancer is prompting patients to seek highly effective treatment approaches, leading to a spike in radiation proctitis incidences, compelling them to seek effective treatment,” remarks a Fact.MR analyst.

radiation proctitis treatment market

Key Takeaways from the Report

  • By indication, acute radiation proctitis treatment remains dominant, with chronic radiation proctitis treatment to expand swiftly
  • Anti-inflammatory drug-based oral therapy to remain the most preferred treatment for radiation proctitis
  • Incorporation of hyperbaric oxygen therapy to fuel radiation proctitis treatment prospects across the U.S.
  • The market in the U.K. experiencing high growth amid increasing cervical cancer treatment procedures
  • Broadening cancer research funding to bolster sales of radiation proctitis treatment solutions in the German market

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5281

Global Radiation Proctitis Treatment Market: Segmentation

  • Indication
    • Acute Radiation Proctitis
    • Chronic Radiation Proctitis
  • Therapy
    • Oral Therapy
      • Antidiarrheal
      • Anti-inflammatory Agents
      • Others
    • Ablative Procedures
    • Hyperbaric Oxygen Therapy
    • Formalin
    • Surgery

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=5281

Following Questions Answers Covered in the Report are:

  • How will the global Radiation Proctitis Treatment Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Radiation Proctitis Treatment Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Radiation Proctitis Treatment Market?
  • How will these strategies influence the market growth and competition?

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights – https://www.biospace.com/article/increasing-and-consistent-investments-for-healthcare-infrastructural-development-is-key-for-driving-neuralgia-treatment-market/

More Valuable Insights

Fact.MR, in its new offering, presents an unbiased analysis of the radiation proctitis treatment market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of indication (acute radiation proctitis and chronic radiation proctitis) and therapy (oral therapy, ablative procedures, hyperbaric oxygen therapy, formalin, and surgery), across five major regions of the world (North America, Latin America, Europe, Asia Pacific, and MEA).

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com